LEP and Miyoshi myopathy: Leptin has been shown to be responsible for reducing the anti-tumor effects of chemotherapy via activation of AKT and STAT3 pathways, as well as upregulating Bcl-2 expression and inhibiting caspase-3 activation in MM cells in vitro (61).